Try the Demo today!
| SEC Filing | Insider | Company | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Return |
|---|---|---|---|---|---|---|---|---|---|
| 20-Sep-24 4:13 PM View:  | Adams Kendra Chief Financial Officer | C4 Therapeutics, Inc. (CCCC) | 18-Sep-24 | Payment of Exercise | 1,837 | $6.38 | $11,720.10 | (2%) 83.63K to 81.79K | |
| 17-Sep-24 5:12 PM View: | Fisher Stewart Chief Scientific Officer | C4 Therapeutics, Inc. (CCCC) | 16-Sep-24 | Payment of Exercise | 661 | $6.36 | $4,203.96 | (< 1%) 131.37K to 130.71K | |
| 17-Sep-24 5:12 PM View: | Adams Kendra Chief Financial Officer | C4 Therapeutics, Inc. (CCCC) | 16-Sep-24 | Option Exercise | 2,250 | -- | -- | 3% 82.04K to 84.29K | |
| 17-Sep-24 5:12 PM View: | Boyle Scott N Chief Business Officer | C4 Therapeutics, Inc. (CCCC) | 16-Sep-24 | Option Exercise | 2,250 | -- | -- | 4% 52.33K to 54.58K | |
| 17-Sep-24 5:12 PM View: | Schick Kelly Chief People Officer | C4 Therapeutics, Inc. (CCCC) | 16-Sep-24 | Payment of Exercise | 661 | $6.36 | $4,203.96 | (1%) 54.5K to 53.84K | |
| 17-Sep-24 5:11 PM View: | Siegel Jolie Chief Legal Officer | C4 Therapeutics, Inc. (CCCC) | 16-Sep-24 | Payment of Exercise | 661 | $6.36 | $4,203.96 | (1%) 54.5K to 53.84K | |
| 17-Sep-24 5:12 PM View: | Hirsch Andrew President & CEO Director | C4 Therapeutics, Inc. (CCCC) | 16-Sep-24 | Option Exercise | 7,500 | -- | -- | 4% 210.74K to 218.24K | |
| 17-Sep-24 5:12 PM View: | Adams Kendra Chief Financial Officer | C4 Therapeutics, Inc. (CCCC) | 16-Sep-24 | Payment of Exercise | 661 | $6.36 | $4,203.96 | (< 1%) 84.29K to 83.63K | |
| 17-Sep-24 5:12 PM View: | Fisher Stewart Chief Scientific Officer | C4 Therapeutics, Inc. (CCCC) | 16-Sep-24 | Option Exercise | 2,250 | -- | -- | 2% 129.12K to 131.37K | |
| 17-Sep-24 5:12 PM View: | Schick Kelly Chief People Officer | C4 Therapeutics, Inc. (CCCC) | 16-Sep-24 | Option Exercise | 2,250 | -- | -- | 4% 52.25K to 54.5K | |
| 17-Sep-24 5:11 PM View: | Siegel Jolie Chief Legal Officer | C4 Therapeutics, Inc. (CCCC) | 16-Sep-24 | Option Exercise | 2,250 | -- | -- | 4% 52.25K to 54.5K | |
| 17-Sep-24 5:12 PM View: | Boyle Scott N Chief Business Officer | C4 Therapeutics, Inc. (CCCC) | 16-Sep-24 | Payment of Exercise | 661 | $6.36 | $4,203.96 | (1%) 54.58K to 53.92K | |
| 17-Sep-24 5:12 PM View: | Hirsch Andrew President & CEO Director | C4 Therapeutics, Inc. (CCCC) | 16-Sep-24 | Payment of Exercise | 3,329 | $6.36 | $21,172.40 | (2%) 218.24K to 214.91K | |
| 11-Jul-24 4:16 PM View: | Reyno Leonard Chief Medical Officer | C4 Therapeutics, Inc. (CCCC) | 10-Jul-24 | Payment of Exercise | 6,191 | $5.00 | $30,955.00 | (6%) 98.0K to 91.81K | |
| 02-Apr-24 4:34 PM View: | Dubin Glenn Director | C4 Therapeutics, Inc. (CCCC) | 01-Apr-24 | Grant | 1,358 | $8.10 | $10,999.80 | < 1% 811.32K to 812.68K | |
| 02-Apr-24 4:35 PM View: | Anderson Kenneth Carl Director | C4 Therapeutics, Inc. (CCCC) | 01-Apr-24 | Grant | 1,389 | $8.10 | $11,250.90 | < 1% 314.69K to 316.07K | |
| 02-Apr-24 4:33 PM View: | Grogan Donna Roy Director | C4 Therapeutics, Inc. (CCCC) | 01-Apr-24 | Grant | 1,697 | $8.10 | $13,745.70 | 8% 21.93K to 23.63K | |
| 15-Feb-24 6:18 PM View: | Hirsch Andrew President & CEO Director | C4 Therapeutics, Inc. (CCCC) | 15-Feb-24 | Payment of Exercise | 6,560 | $7.90 | $51,824.00 | (3%) 217.3K to 210.74K | |
| 15-Feb-24 5:03 PM View: | Boyle Scott N Chief Business Officer | C4 Therapeutics, Inc. (CCCC) | 14-Feb-24 | Grant | 27,300 | -- | -- | 109% 25.03K to 52.33K | |
| 15-Feb-24 5:08 PM View: | Hirsch Andrew President & CEO Director | C4 Therapeutics, Inc. (CCCC) | 14-Feb-24 | Grant | 103,400 | -- | -- | 91% 113.9K to 217.3K | |
| 15-Feb-24 5:04 PM View: | Fisher Stewart Chief Scientific Officer | C4 Therapeutics, Inc. (CCCC) | 14-Feb-24 | Grant | 27,300 | -- | -- | 27% 101.82K to 129.12K | |
| 10-Apr-24 4:16 PM View: | Mossler Mark Chief Accounting Officer | C4 Therapeutics, Inc. (CCCC) | 14-Feb-24 | Grant | 18,290 | -- | -- | 1219% 1.5K to 19.79K | |
| 15-Feb-24 5:05 PM View: | Schick Kelly Chief People Officer | C4 Therapeutics, Inc. (CCCC) | 14-Feb-24 | Grant | 27,300 | -- | -- | 109% 24.95K to 52.25K | |
| 15-Feb-24 5:07 PM View: | Siegel Jolie Chief Legal Officer | C4 Therapeutics, Inc. (CCCC) | 14-Feb-24 | Grant | 27,300 | -- | -- | 109% 24.95K to 52.25K | |
| 15-Feb-24 5:08 PM View: | Reyno Leonard Chief Medical Officer | C4 Therapeutics, Inc. (CCCC) | 14-Feb-24 | Grant | 36,700 | -- | -- | 60% 61.3K to 98.0K | |
| 15-Feb-24 5:02 PM View: | Adams Kendra Chief Financial Officer | C4 Therapeutics, Inc. (CCCC) | 14-Feb-24 | Grant | 36,700 | -- | -- | 81% 45.34K to 82.04K | |
| 15-Feb-24 5:02 PM View: | Adams Kendra Chief Financial Officer | C4 Therapeutics, Inc. (CCCC) | 13-Feb-24 | Payment of Exercise | 1,301 | $6.53 | $8,495.53 | (3%) 46.64K to 45.34K | |
| 15-Feb-24 5:03 PM View: | Boyle Scott N Chief Business Officer | C4 Therapeutics, Inc. (CCCC) | 13-Feb-24 | Payment of Exercise | 1,735 | $6.53 | $11,329.60 | (6%) 26.77K to 25.03K | |
| 15-Feb-24 5:04 PM View: | Fisher Stewart Chief Scientific Officer | C4 Therapeutics, Inc. (CCCC) | 13-Feb-24 | Payment of Exercise | 2,255 | $6.53 | $14,725.20 | (2%) 104.08K to 101.82K | |
| 15-Feb-24 5:05 PM View: | Schick Kelly Chief People Officer | C4 Therapeutics, Inc. (CCCC) | 13-Feb-24 | Payment of Exercise | 1,735 | $6.53 | $11,329.60 | (7%) 26.69K to 24.95K | |
| 15-Feb-24 5:07 PM View: | Siegel Jolie Chief Legal Officer | C4 Therapeutics, Inc. (CCCC) | 13-Feb-24 | Payment of Exercise | 1,735 | $6.53 | $11,329.60 | (7%) 26.69K to 24.95K | |
| 03-Jan-24 4:11 PM View: | Anderson Kenneth Carl Director | C4 Therapeutics, Inc. (CCCC) | 02-Jan-24 | Grant | 1,725 | $6.52 | $11,247.00 | < 1% 312.96K to 314.69K | |
| 03-Jan-24 4:10 PM View: | Grogan Donna Roy Director | C4 Therapeutics, Inc. (CCCC) | 02-Jan-24 | Grant | 2,108 | $6.52 | $13,744.20 | 11% 19.83K to 21.93K | |
| 03-Jan-24 4:12 PM View: | Dubin Glenn Director | C4 Therapeutics, Inc. (CCCC) | 02-Jan-24 | Grant | 1,687 | $6.52 | $10,999.20 | < 1% 809.64K to 811.32K | |
| 03-Oct-23 4:26 PM View: | Grogan Donna Roy Director | C4 Therapeutics, Inc. (CCCC) | 02-Oct-23 | Grant | 8,089 | $1.70 | $13,751.30 | 69% 11.74K to 19.83K | |
| 03-Oct-23 4:27 PM View: | Dubin Glenn Director | C4 Therapeutics, Inc. (CCCC) | 02-Oct-23 | Grant | 6,470 | $1.70 | $10,999.00 | < 1% 803.17K to 809.64K | |
| 03-Oct-23 4:28 PM View: | Anderson Kenneth Carl Director | C4 Therapeutics, Inc. (CCCC) | 02-Oct-23 | Grant | 6,617 | $1.70 | $11,248.90 | 2% 306.34K to 312.96K | |
| 19-Sep-23 7:21 PM View: | Adams Kendra Chief Financial Officer | C4 Therapeutics, Inc. (CCCC) | 18-Sep-23 | Grant | 25,000 | -- | -- | 116% 21.64K to 46.64K | |
| 31-Aug-23 4:09 PM View: | Boyle Scott N Chief Business Officer | C4 Therapeutics, Inc. (CCCC) | 30-Aug-23 | Payment of Exercise | 661 | $2.93 | $1,936.73 | (2%) 27.43K to 26.77K | |
| 31-Aug-23 4:10 PM View: | Schick Kelly Chief People Officer | C4 Therapeutics, Inc. (CCCC) | 30-Aug-23 | Option Exercise | 2,250 | -- | -- | 9% 25.1K to 27.35K | |
| 31-Aug-23 4:12 PM View: | Siegel Jolie Chief Legal Officer | C4 Therapeutics, Inc. (CCCC) | 30-Aug-23 | Option Exercise | 2,250 | -- | -- | 9% 25.1K to 27.35K | |
| 31-Aug-23 4:13 PM View: | Hirsch Andrew President & CEO Director | C4 Therapeutics, Inc. (CCCC) | 30-Aug-23 | Payment of Exercise | 2,205 | $2.93 | $6,460.65 | (2%) 116.11K to 113.9K | |
| 31-Aug-23 4:10 PM View: | Fisher Stewart Chief Scientific Officer | C4 Therapeutics, Inc. (CCCC) | 30-Aug-23 | Payment of Exercise | 661 | $2.93 | $1,936.73 | (< 1%) 104.74K to 104.08K | |
| 31-Aug-23 4:10 PM View: | Schick Kelly Chief People Officer | C4 Therapeutics, Inc. (CCCC) | 30-Aug-23 | Payment of Exercise | 661 | $2.93 | $1,936.73 | (2%) 27.35K to 26.69K | |
| 31-Aug-23 4:12 PM View: | Siegel Jolie Chief Legal Officer | C4 Therapeutics, Inc. (CCCC) | 30-Aug-23 | Payment of Exercise | 661 | $2.93 | $1,936.73 | (2%) 27.35K to 26.69K | |
| 31-Aug-23 4:11 PM View: | White Lauren Chief Financial Officer | C4 Therapeutics, Inc. (CCCC) | 30-Aug-23 | Option Exercise | 2,250 | -- | -- | 7% 31.1K to 33.35K | |
| 31-Aug-23 4:09 PM View: | Boyle Scott N Chief Business Officer | C4 Therapeutics, Inc. (CCCC) | 30-Aug-23 | Option Exercise | 2,250 | -- | -- | 9% 25.18K to 27.43K | |
| 31-Aug-23 4:11 PM View: | White Lauren Chief Financial Officer | C4 Therapeutics, Inc. (CCCC) | 30-Aug-23 | Payment of Exercise | 661 | $2.93 | $1,936.73 | (2%) 33.35K to 32.69K | |
| 31-Aug-23 4:13 PM View: | Hirsch Andrew President & CEO Director | C4 Therapeutics, Inc. (CCCC) | 30-Aug-23 | Option Exercise | 7,500 | -- | -- | 7% 108.61K to 116.11K | |
| 31-Aug-23 4:10 PM View: | Fisher Stewart Chief Scientific Officer | C4 Therapeutics, Inc. (CCCC) | 30-Aug-23 | Option Exercise | 2,250 | -- | -- | 2% 102.49K to 104.74K |
